Takeda to buy GammaDelta to accelerate allogeneic cell therapies development

Takeda to buy GammaDelta to accelerate allogeneic cell therapies development

Source: 
Pharmaceutical Business Review
snippet: 

Takeda Pharmaceutical has exercised its option to acquire GammaDelta Therapeutics to accelerate development of allogeneic γδT cell therapies to address solid tumours.